Irbesartan, an angiotensin II receptor antagonist used to treat hypertension, is typically classified under HS code 30049079, which covers medicaments containing mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or forms for retail sale. However, classification disputes may arise concerning whether Irbesartan should be classified under HS code 3003 or 3004.
- HS Code 3003: This code pertains to medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or forms for retail sale.
- HS Code 3004: This code covers medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or forms for retail sale.
The primary distinction lies in the packaging and presentation of the product. Irbesartan in tablet form, packaged for retail sale, should be classified under HS code 3004. Misclassification can occur if the product is incorrectly declared under HS code 3003, leading to potential customs penalties, delays, and incorrect duty assessments.
Our data indicates that 91.0% of Irbesartan shipments are correctly classified under HS code 30049079. However, the use of 14 different HS codes across 2,746 shipments suggests inconsistencies in classification practices. To mitigate misclassification risks, it's crucial to ensure accurate product descriptions and adhere to the specific criteria outlined in the HS nomenclature. Consulting recent World Customs Organization (WCO) rulings and national customs authorities can provide guidance on proper classification and help avoid potential disputes.
